Synthon Hispania, S.L. (manufacturing, primary, secondary packaging, quality control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular morbidity and mortality in adults with heart failure and impaired left ventricular function (following myocardial infarction or in chronic heart failure).
Dosage form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular morbidity and mortality in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in class II chronic heart failure).
Dosage form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
-
The drug is intended for the treatment of hormone receptor-positive (HR-positive) and HER2 receptor-negative breast cancer (locally advanced or metastatic). It is used in combination with aromatase inhibitors or in combination with fulvestrant.
Dosage form: tablets, film-coated
Active substance Dosage palbociclib 75 mg ATC: L01EF01
-
The drug is intended for the treatment of hormone receptor-positive (HR-positive) and HER2-negative locally advanced or metastatic breast cancer. It is used in combination with an aromatase inhibitor or in combination with fulvestrant (for women who have previously received endocrine therapy).
Dosage form: tablets, film-coated
Active substance Dosage palbociclib 100 mg ATC: L01EF01
-
The drug is intended for the treatment of hormone receptor-positive (HR-positive) and HER2-negative locally advanced or metastatic breast cancer. It is used in combination with an aromatase inhibitor or in combination with fulvestrant (for women who have previously received endocrine therapy).
Dosage form: tablets, film-coated
Active substance Dosage palbociclib 125 mg ATC: L01EF01
-
The drug is used to treat functional urinary tract disorders occurring in benign prostatic hyperplasia (enlargement of the prostate gland).
Dosage form: capsules, modified release, hard
Active substance Dosage tamsulosin 0.4 mg ATC: G04CA02
-
The drug is used to treat lower urinary tract symptoms associated with benign prostatic hyperplasia (enlargement of the prostate gland).
Dosage form: tablets, extended-release
Active substance Dosage tamsulosin 0.4 mg ATC: G04CA02